Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Invest ; 48(4): 768-74, 1969 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-5304832

RESUMO

Triiodothyronine (liothyronine sodium) (400-500 mug/day for 14 days) was given to six normal subjects. Factor VIII (antihemophilic globulin) activity increased from 109 to 167% (P < 0.05); fibrinogen increased from 344 to 581 mg/100 ml (P < 0.01). To test whether the increases in factor VIII activity and fibrinogen were mediated by beta adrenergic receptors, propranolol (20 mg every 6 hr) was given orally to four other normal subjects in addition to triiodothyronine for 14 days. Factor VIII increased from 100 to 161%; fibrinogen increased from 374 to 564% (P < 0.01). Factor VIII activity did not change in a severe classical hemophiliac made hypermetabolic with triiodothyronine, but it increased from 39 to 82% in a patient with von Willebrand's disease. Triiodothyronine-induced hypermetabolism increased the incorporation of selenomethionine-(75)Se into plasma fibrinogen. These results suggest that the increases in clotting factor activity during triiodothyronine-induced hypermetabolism reflect an effect of increased protein synthesis rather than enhanced stimulation of beta adrenergic receptors.


Assuntos
Metabolismo Basal/efeitos dos fármacos , Fator VIII/metabolismo , Fibrinogênio/metabolismo , Células Receptoras Sensoriais/efeitos dos fármacos , Tri-Iodotironina/farmacologia , Epinefrina/farmacologia , Fator VIII/análise , Fibrinogênio/análise , Hemofilia A/sangue , Humanos , Hipertireoidismo/sangue , Masculino , Metionina/sangue , Propranolol/farmacologia , Selênio , Tiroxina/farmacologia , Doenças de von Willebrand/sangue
3.
Nutr Rev ; 25(7): 222-3, 1967 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-6047059
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...